Descrizione del progetto
Promuovere l’integrazione tra ingegneria biomedica, biologia e medicina
Il progetto MOBILIsE, finanziato dall’UE, intende promuovere l’integrazione tra ingegneria biomedica, biologia e medicina, grazie a un’enfasi posta sulle interazioni che avvengono a livello molecolare e che hanno conseguenze sulla salute umana. Il progetto si concentrerà inoltre sul cancro, sulle infezioni, sulle malattie neurodegenerative e sulla riparazione e rigenerazione dei tessuti. In tale contesto, si recluterà un ricercatore o una ricercatrice da nominarsi titolare della cattedra dello Spazio europeo della ricerca (SER) presso l’Istituto di ingegneria biomedica (INEB) in Portogallo. Il titolare della cattedra guiderà la ricerca nel campo della bioingegneria molecolare, con un’attenzione particolare rivolta alla medicina di precisione e, nello specifico, alle terapie mirate e alla diagnosi molecolare. In ultima analisi, MOBILIsE istituirà un gruppo di ricerca nell’ambito della bioingegneria molecolare che rafforzerà ulteriormente l’eccellenza di ricerca dell’INEB.
Obiettivo
MOBILIsE aims to recruit an outstanding Researcher to act as the ERA Chair Holder to the National Institute of Biomedical Engineering (INEB). She/he will establish a new research direction in Molecular Bioengineering focused on precision medicine, namely in targeted therapies and molecular diagnosis, and create a synergic and cohesive research environment among key stakeholders (academy, research institutes, clinicians and industry) in the Porto region: the MOBILIsE hub. The MOBILIsE project will boost the translation of the design of new molecular targets to the application of diagnostic tools and therapies targeted to the major health challenges, with particular focus on cancer, infection, neurodegenerative diseases, and tissue repair/regeneration that have been explored at the institute. INEB is already recognized for its fundamental work in protein/cell-materials interactions and in the development of nanotechnology tools for targeted controlled drug delivery. Yet, the potential and projection at international level of cross-disciplinary research, like the application of nanomedicine to cancer and neurologic disorders, is still limited. This has a major impact on funding attraction, transfer of technology, and translational potential of the research developed. Hence, this project will hire an expert in Molecular Bioengineering to install an internationally competitive research group focused on precision medicine. The group will exploit nanotechnology tools to discover new molecular targets that can be explored in the design of new diagnostic and/or therapeutic systems. The MOBILIsE project will promote the integration between biomedical engineering, biology and medicine, by focusing on (vital) interactions at the molecular level with impact on human health. Ultimately, MOBILIsE aims to establish a Molecular Bioengineering research group that will facilitate critical institutional structural changes to maximize the high potential for research excellence at INEB.
Campo scientifico
Programma(i)
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-WIDESPREAD-2018-2020-6
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
4200 135 Porto
Portogallo